CLINICAL_TRIALS
safety_alert
· 2017-03-27
Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Xianlin Gubao Granule
Summary
Ongoing safety surveillance is being conducted to monitor potential early liver injuries associated with Xianlin Gubao Granule.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing 302 Hospital | Conditions: Drug-Induced Liver Injury | Status: UNKNOWN